8008-1816 Screening compound: 2-({6-[(E)-[(anthracen-9-yl)methylidene]amino]-1,3-benzothiazol-2-yl}sulfanyl)-N-[2-(methylsulfanyl)-1,3-benzothiazol-6-yl]acetamide

8008-1816 Screening compound: 2-({6-[(E)-[(anthracen-9-yl)methylidene]amino]-1,3-benzothiazol-2-yl}sulfanyl)-N-[2-(methylsulfanyl)-1,3-benzothiazol-6-yl]acetamide
8008-1816 Screening compound: 2-({6-[(E)-[(anthracen-9-yl)methylidene]amino]-1,3-benzothiazol-2-yl}sulfanyl)-N-[2-(methylsulfanyl)-1,3-benzothiazol-6-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 8008-1816
2-({6-[(E)-[(anthracen-9-yl)methylidene]amino]-1,3-benzothiazol-2-yl}sulfanyl)-N-[2-(methylsulfanyl)-1,3-benzothiazol-6-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

8008-1816

Molecular Formula

C32H22N4OS4 (C32 H22 N4 OS4)

Compound Name

2-({6-[(E)-[(anthracen-9-yl)methylidene]amino]-1,3-benzothiazol-2-yl}sulfanyl)-N-[2-(methylsulfanyl)-1,3-benzothiazol-6-yl]acetamide

IUPAC name

2-({6-[(E)-[(anthracen-9-yl)methylidene]amino]-13-benzothiazol-2-yl}sulfanyl)-N-[2-(methylsulfanyl)-13-benzothiazol-6-yl]acetamide

SMILES

CSc1nc(ccc(NC(CSc2nc(ccc(/N=C/c3c(cccc4)c4cc4ccccc34)c3)c3s2)=O)c2)c2s1

InChI

InChI=1S/C32H22N4OS4/c1-38-31-35-26-13-11-22(16-29(26)40-31)34-30(37)18-39-32-36-27-12-10-21(15-28(27)41-32)33-17-25-23-8-4-2-6-19(23)14-20-7-3-5-9-24(20)25/h2-17H,18H2,1H3,(H,34,37)

InChI Key

BVPAWUKIBQJBNP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01204430

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

606.82

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

9.041

Distribution Coefficient, logD

9.041

Water Solubility, LogSw

-6.70

Polar Surface Area

48.863

Acid Dissociation Constant (pKa)

11.87

Base Dissociation Constant (pKb)

4.20

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

6.30

8008-1816 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with 8008-1816 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 8008-1816?
Check Price and Availability of 8008-1816, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 8008-1816 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 8008-1816
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 8008-1816
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 8008-1816 available by request